CSR vs NHI

For growth investors, Centerspace (CSR) is the stronger pick with 35.

3% revenue growth year-over-year, versus 12. 9% for National Health Investors, Inc. (NHI). National Health Investors, Inc. (NHI) offers the better valuation at 24. 5x trailing P/E (21. 8x forward), making it the more compelling value choice. Analysts rate Centerspace (CSR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, National Health Investors, Inc.

(NHI) is the cheapest at 24. 5x versus Centerspace at 65. 9x.

Over the past 5 years, National Health Investors, Inc.

(NHI) delivered a total return of +29. 5%, compared to +17. 5% for Centerspace (CSR). Over 10 years, the gap is even starker: NHI returned +60. 5% versus CSR's +53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), National Health Investors, Inc.

(NHI) is the lower-risk stock at -0. 08β versus Centerspace's 0. 29β — meaning CSR is approximately -448% more volatile than NHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 121% for Centerspace — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Centerspace (CSR) is pulling ahead at 35.

3% versus 12. 9% for National Health Investors, Inc. (NHI). On earnings-per-share growth, the picture is similar: Centerspace grew EPS 180. 3% year-over-year, compared to -3. 5% for National Health Investors, Inc.. Over a 3-year CAGR, CSR leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

National Health Investors, Inc.

(NHI) is the more profitable company, earning 37. 6% net margin versus 5. 0% for Centerspace — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 29. 2% for CSR. At the gross margin level — before operating expenses — NHI leads at 36. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for NHI: 15.

6% to $85. 40.

All stocks in this comparison pay dividends.

National Health Investors, Inc. (NHI) offers the highest yield at 4. 9%, versus 4. 5% for Centerspace (CSR).

For long-horizon retirement investors, National Health Investors, Inc.

(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +60. 5%, CSR: +53. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CSR is a small-cap high-growth stock; NHI is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.